References
- Chantada G, Fandirio A, Mato G, et al. A phase II window of idarubicin in children with extraocular retinoblastoma. J Clin Oncol. 1999;17:1847–1850.
- Doz F, Neuenshwander S, Plantaz D, et al. Etoposide and carboplatin in extraocular retinoblastoma: a study by the Societe Française d'Oncologie Pédiatrique. J Guth Oncol. 1995;13:932–909.
- Kretschmar C, Kletzel M, Murray K. Upfront phase II therapy with taxol (txl) and topotecan (topo) in untreated children (365 days) with disseminated neuroblastoma (NB). A Pediatric Oncology Group Study (Abstract). Med Pediatr Oncol. 1995;25: 243.
- Pappo A, Lyden E, Breneman J, et al. Upfront window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an Intergroup Rhabdomyosarcoma Study. J Clin Oncol. 2001;19:213–219.
- Nitiss JL, Wang JC. Mechanisms of cell killing by drugs that trap covalent complexes between DNA topoisomerases and DNA. Mol Pharmacol.I996:5o;1095–1102.
- Frangoul H, Ames M, Mosher R, et al. Phase I study of topotecan administered as a 21-day continuous infusion in children with recurrent solid tumors: a report from the Children's Cancer Group. Clin Cancer Res. 1999:5;3956–3962.
- Nitschke R, Parkhurst J, Sullivan J, et al. Topotecan in pediatric patients with recurrent and progressive solid tumors: a Pediatric Oncology Group Phase II Study. J Pediatr Hematol Oncol. 1998;20:315–318.
- Grabowski E, Abramson D. Intraocular and extraocular retinoblastoma. Hematol Oncol Clin North Am. 1987;1:721–735.
- Pratt CB, Crom DB, Howarth C. The use of chemotherapy for extraocular retinoblastoma. Med Pediatr Oncol. 1985;13(6):330–333.
- Baker SD, Heideman RL, Crom WR, et al. Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors. Cancer Chem other Pharmacol. 1996;37(3):195–202.
- Blaney SM, Heideman R, Berg S, et al. Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis. J Clin Oncol. 2003;21: 143–147.
- Chan H, Canton M, Gallie B. Chemosensitivity and multidrug resistance to antineoplastic drugs in retinoblastoma cell lines. Anticancer Res. 1989;9:469–474.